Levels of myocardial biomarkers before and after ePCI, in-hospital MACEs, and bleeding events in the BUDO and BUDAO groups
bleeding, cardiac death
ACUTE MYOCARDIAL INFARCTION, BLEEDING, CARDIAC DEATH, AMI, EVENTS
Before ePCI, CK-MB and cTnI levels were similar in the BUDO and BUDAO groups (Levels of myocardial biomarkers before and after ePCI in the BUDO and BUDAO groups. (The incidence of in-hospital MACEs, including target vessel (TV) acute myocardial infarction (AMI), TVR, and TV cardiac death (CD), was not significantly higher in the BUDO group compared to the BUDAO group (In-hospital MACEs and bleeding events in the BUDO and BUDAO groups.Data were expressed as n (%). These results indicate that prolonged use of bivalirudin after ePCI could reduce PMI in patients undergoing ePCI without increasing the risk of bleeding.